D. R. Rustamova

D. R. Rustamova

Auto-generated profile, based on publicly available information

D. R. Rustamova

Burdenko Neurosurgical Center

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2026 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
AAA.D. Akhmedov
A.D. Akhmedov
VLV.A. Lukshin
V.A. Lukshin
SZS.V. Zolotova
S.V. Zolotova
DKD.S. Kim
D.S. Kim
DRD.R. Rustamova
D.R. Rustamova
DUDmitriy Usachev
Dmitriy Usachev
Background. Head and neck tumors cross several clinical specialties. Diagnostic and treatment approaches vary significantly depending on specialty, and there is no a unified diagnostic standard for paragangliomas in these areas. In this report, we summarize available data on these tumors and present own patient evaluation protocol. Objective. To systematize modern information on epidemiology, pathogenesis and diagnosis of paragangliomas. Material and methods. We present literature review and retrospective analysis of instrumental and laboratory data of patients with head and neck paragangliomas. Results. We analyzed modern diagnostic methods: imaging (Doppler ultrasound, CT, MRI, PET CT), biochemical (catecholamines and their metabolites), and molecular genetic (mutation testing) tests. Advantages and limitations of each method were identified. We also present optimal algorithms for their combination for early and accurate disease detection. Conclusion. This analysis systematized the approach to diagnostic algorithm for patients with head and neck paragangliomas. The capabilities of modern imaging methods allow for identification of potentially malignant and familial forms of disease, which are fundamentally different from sporadic forms. Available data underlie a differentiated approach to treatment strategy. This positively impacts treatment outcomes. This aspect will be discussed in the second part of the article.

30 March 2026 in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
Verified
Journal Article
Closed access
NIN. N. Isakov
N. N. Isakov
VNV. V. Nazarov
V. V. Nazarov
DRD. R. Rustamova
D. R. Rustamova
TNT. A. Nikishin
T. A. Nikishin
AKA. B. Kadasheva
A. B. Kadasheva
VCV. A. Cherekaev
V. A. Cherekaev
Hyperostotic craniofacial meningiomas (HCM) represent a complex neurosurgical problem due to their widespread infiltrative growth, involvement of critical anatomical structures, and a high risk of recurrence. Treatment of recurrences requires a comprehensive approach taking into account the location, extent of the lesion, and involvement of critical anatomical structures. Purpose: to analyze and summarize current surgical tactics for the treatment of recurrent hyperostotic craniofacial meningiomas, including an assessment of the effectiveness of various surgical approaches, defect reconstruction methods, and adjuvant treatments based on literature data. Materials and methods. An analytical review of the literature and a synthesis of study data were conducted with an emphasis on classification, epidemiology of recurrence, and risk factors for recurrence. An analysis of current surgical tactics for the treatment of recurrent hyperostotic craniofacial meningiomas was performed based on a systematic review of the literature. The review includes data on the use of transcranial, craniofacial, and endonasal endoscopic approaches, as well as reconstruction and adjuvant therapy methods. Results. The recurrence rate of HCM was found to reach 29% with a mean follow-up period of 76.5 months, with 23% of patients experiencing more than one recurrence. The main factors influencing the risk of recurrence are the degree of radical resection, histological grade (WHO), Ki-67 index, and medial tumor spread. Modern surgical approaches, including combined approaches and individual reconstruction of defects, allow for good functional and aesthetic results. The use of stereotactic radiosurgery as an adjuvant method demonstrates high rates of local tumor control. Conclusion. Surgery for recurrent HCM is a safe and effective treatment method that requires careful planning taking into account previous interventions, current tumor spread, and a multidisciplinary approach. Integration of adjuvant radiation therapy into the treatment of recurrences, particularly after subtotal resections and for high-grade tumors, is essential for improving recurrence-free survival.